ﺑﺎﺯﮔﺸﺖ ﺑﻪ ﺻﻔﺤﻪ ﻗﺒﻠﯽ
خرید پکیج
تعداد آیتم قابل مشاهده باقیمانده : 2 مورد
نسخه الکترونیک
medimedia.ir

Supraglottic airways (SGAs) for airway management for anesthesia in adults

Supraglottic airways (SGAs) for airway management for anesthesia in adults
Literature review current through: May 2024.
This topic last updated: Apr 29, 2024.

INTRODUCTION — Supraglottic airways (SGAs) are a group of airway devices that can be inserted into the pharynx to allow ventilation, oxygenation, and administration of anesthetic gases, without the need for endotracheal intubation. For anesthesia, these devices are used for primary airway management, for rescue ventilation when facemask ventilation is difficult, and as a conduit for endotracheal intubation.

The SGAs that are used most commonly in the operating room are the laryngeal mask airways (LMAs) and similar devices. These consist of a hollow shaft or tube connected to a mask-like cuff designed to sit in the hypopharynx facing the glottis, with the tip at the esophageal inlet (figure 1 and picture 1). Other devices used more commonly in the emergency department and for prehospital airway management are referred to as extraglottic devices (eg, Combitube, laryngeal tube, pharyngeal tube).

This topic will discuss SGAs as they are used in anesthesia for adults, including placement and ventilation techniques, endotracheal intubation through the LMA, and use in special clinical situations. Use of other airway devices in anesthesia is discussed separately. (See "Airway management for induction of general anesthesia", section on 'Choice of airway device'.)

Use of SGAs and other extraglottic devices in emergency medicine is discussed separately. (See "Extraglottic devices for emergency airway management in adults".)

ROUTINE USE OF SGAS — The laryngeal mask airway (LMA) is used clinically as an alternative to both mask ventilation and endotracheal intubation. It is usually easily placed and is less stimulating than endotracheal intubation, but it does not provide complete protection against aspiration and does not prevent laryngospasm. Choice of airway device for anesthesia is discussed separately. (See "Airway management for induction of general anesthesia", section on 'Choice of airway device'.)

Choice of SGA — Unless cost is an issue, for most patients we prefer to use the more advanced second-generation devices that include bite blocks and esophageal vents. In addition, when the need for high ventilation pressure is anticipated, we prefer an SGA specifically designed for that purpose (eg, LMA ProSeal).

There are multiple types of reusable and disposable SGAs (picture 2 and picture 3). Although the LMA is the oldest and best known brand, a number of other companies manufacture SGAs.

Classification of SGAs — SGAs are often referred to as first, second, or third generation devices, though second and third generation are variably defined.

First generation SGAs The original LMA and similar devices are referred to as first-generation SGAs. They include an airway tube with a mask-like cuff (figure 1). Some brands duplicate the functionality of the original LMA at lower cost (eg, products from Portex [Portex Soft Seal] and Ambu [AuraStraight]), while others are materially different from the original LMA (eg, air-Q, Ambu Aura-i, LMA Supreme).

First generation devices were primarily used in spontaneously breathing patients undergoing short surgical procedures.

Second generation SGAs Second-generation SGAs may include additional features such as bite blocks, cuffs designed to improve the seal, esophageal vents that allow orogastric tube placement, cuff pressure monitors, and in one case, a lumen that allows passage of an upper gastrointestinal endoscope (figure 2). Examples of second-generation products include the LMA ProSeal (picture 4), the LMA Supreme (picture 5) and the LMA Fastrach (picture 6), the i-gel (picture 7), and the Air-Q blocker (picture 8).

Third generation SGAs Some experts consider the most recently developed SGAs with video capabilities to be the third generation of SGAs [1-3].

Unique features — Examples of unique features incorporated into various devices include the following:

A number of SGAs contain aperture bars (a grill) over the laryngeal inlet. This feature serves to prevent the epiglottis from entering the shaft of the SGA (picture 9). The epiglottis can interfere with ventilation and with the visualization of glottic structures with a flexible intubating scope [4], though the clinical significance of this feature has been disputed [5].

Flexible, reinforced SGAs have wire-reinforced, flexible airway tubes with a smaller diameter than other SGAs. These features allow them to be positioned away from the surgical field without kinking, which is particularly useful for otolaryngologic, dental, and other head and neck procedures in which the surgeon and anesthesiologist share the airway or the surgical field. Examples include the LMA flexible, the Ambu AuraFlex, and the Tru-Cuff Ultra Flex EX (picture 10).

Some SGAs incorporate a preformed curved airway tube that facilitates placement. Examples include the Ambu AuraOnce, the Ambu Aura Gain, the LMA Supreme, and the LMA Protector (picture 5).

Some SGAs include features designed to prevent high-pressure overinflation of the cuff. The Tru-Cuff LM inflation syringe has a built-in pressure indicator. After the device is inserted, the cuff is inflated until the indicator is in the green zone on the syringe (40 to 60 mmHg) (picture 11). Another device, the air-Q SP, has a self-inflating, low-pressure cuff (picture 12). (See 'Role of cuff pressure' below.)

The i-gel differs from other SGAs in that its gel cuff is not inflatable, yet it provides an excellent seal and eliminates concerns about cuff pressures (picture 7). The i-gel has a gastric vent, an integral bite block, and a flange designed to prevent epiglottic folding.

A number of SGAs may be used as conduits for endotracheal intubation. Examples include the LMA Fastrach, the air-Q intubating laryngeal airway (ILA), the i-gel, the Ambu Aura Gain, and the LMA protector (picture 6 and picture 13 and picture 7). The LMA Fastrach is designed to be used for intubation and then removed. The other four listed SGAs can be used as primary airway devices. (See 'Supraglottic airways as conduits for intubation' below.)

The LMA Gastro Airway was developed for use during upper gastrointestinal endoscopy, and allows passage of an endoscope through a dedicated lumen while providing an unobstructed airway (figure 2). In an open label observational study including 292 patients who underwent upper endoscopy with general anesthesia, rates for successful LMA insertion and successful endoscope insertion were both 99 percent [6]. The only notable adverse event was hospital admission for a sore throat with inability to tolerate oral fluids in one patient. In a small study, the LMA Gastro was used for endoscopic retrograde cholangiopancreatography without complications [7].

Large diameter endoscopes (eg, ultrasound capable gastroscopes) may not pass easily through the LMA Gastro; before using the LMA Gastro, the intended gastroscope should be tested to make sure it passes easily through the LMA.

Video SGA — Video SGAs are a new type of device that allow vision-guided insertion and confirmation of correct placement. These incorporate a dead end channel that accepts a reusable proprietary videoscope, in addition to features of a second generation SGA (eg, a gastric drainage channel). With the videoscope inserted, the lens is within the bowl of the SGA. Video SGAs are placed in the same way as other SGAs, after which the videoscope is removed. (See 'Placement technique' below.)

Video SGAs may reduce or eliminate incorrect SGA placement, and can also be used to facilitate endotracheal intubation if necessary.

Multiple studies using various confirmation techniques have found that blindly inserted SGAs are suboptimally positioned in as many as 80 percent of cases [8-10]. Malpositioning is often unrecognized, and can cause gastric insufflation, aspiration, leak of gas around the cuff and inadequate ventilation, or airway injury. Several studies have reported successful correct SGA placement in >95 percent of video SGA assisted insertions [11,12]. (See 'Supraglottic airway-related complications' below.)

Several models of video SGAs have been introduced into the market. Examples are the UE Medical SaCoVLM, and the SafeLM Video Laryngeal Mask system. The latter allows adjustment of the tip of the videoscope to visualize the entire glottis.

Experience with these devices is limited and their role in routine practice has not been established.

Choice of size — Most SGAs come in full sizes (eg, 3, 4, 5, 6), though some are available in half sizes (eg, 3.5, 4.5). While manufacturers' guidelines recommend weight-based size selection, these guidelines generally assume a typical body habitus (table 1 and table 2). Predicting optimal sizing is complex as an optimal seal depends on a number of factors, including the size of the device, the cuff inflation, and patient anatomy [13-16].

SGA manufacturers provide guidelines for the maximum volume of air to be used for cuff inflation. Suggested cuff volumes are 30 mL for a size-4 SGA and 40 mL for a size-5 SGA. If a high cuff volume is required in order to maintain a seal, we usually replace the device with a larger size. A better seal may be obtained using a larger size with less air. Using too small a device and overinflating the cuff may result in a poor fit within the oropharyngeal space and may injure the oropharyngeal mucosa. (See 'Role of cuff pressure' below.)

In general, a size-4 SGA will be suitable for most adult females and a size-5 for adult males up to 100 kg. Ultimately, choice of SGA size is as much an art as a science. In many cases, if the initial size chosen does not provide adequate ventilation (eg, large leak at any cuff volume), a different size SGA should be tried, or endotracheal intubation should be performed.

Placement technique — Adequate depth of anesthesia with intravenous (IV) or inhalation anesthetics is generally established before SGA placement in order to avoid coughing, gagging, laryngospasm, breath holding, or straining. Successful placement in awake patients with adequate topical oropharyngeal anesthesia has also been described [17]. In general, SGA placement is less stimulating than endotracheal intubation.

Several methods for SGA placement have been described; we generally follow the manufacturer's instructions for placement of the LMA Classic before attempting alternate methods. The technique is summarized as follows (figure 3):

Lubricate the cuff with a water-based lubricant.

Hold the device with the index finger of the dominant hand placed at the junction between the cuff and the airway tube.

Press the cuff upward against the hard palate with the index finger, then backward and downward along the palate in a smooth movement until resistance is encountered. As the index finger is removed, use the nondominant hand to hold the LMA down and prevent dislodgement.

Inflate the cuff to a target cuff pressure of around 44 mmHg, or to the minimum pressure needed to create an adequate seal [18].

With correct insertion, the SGA sits over the glottis, with the epiglottis lying within the mask aperture. Clinical confirmation of correct positioning can be established by the following:

Easy positive pressure ventilation (PPV), requiring low ventilation pressures

Appropriate chest rise with each breath

A normal capnogram trace

No leak with positive pressure breaths under 20 mmHg peak pressure

With correct positioning, the tube may move outward as the cuff is inflated, and a slight swelling in the neck may occur. However, some malpositions may not be clinically apparent and may not be identified unless a flexible intubation scope is used. Common causes of malposition include a down-folded epiglottis or a flipped-over SGA cuff, which may require reinsertion. (See 'Troubleshooting' below.)

Once insertion is complete, cuff pressure can be measured with a manometer designed for this purpose, unless an SGA with a built-in manometer is used (picture 14). (See 'Role of cuff pressure' below.)

Other SGAs are placed in a similar fashion to the LMA Classic, with the exception of the LMA Supreme, which has a fixation tab that allows placement without inserting the finger into the patient's mouth.

Troubleshooting — Although SGAs are usually placed successfully, problems with insertion or ventilation occur. Malpositions can sometimes be managed by repositioning the patient's head, readjusting the SGA position, or adjusting the air in the cuff. When in doubt, we advise removing and reinserting the SGA or, occasionally, converting to endotracheal intubation.

Inadequate anesthesia – Initial difficulty with placement of an SGA may be due to inadequate anesthesia, such that the patient strains, breath holds, or maintains upper airway tone, preventing seating of the device. Insufficient depth of anesthesia may also cause laryngospasm or bronchospasm, resulting in airway obstruction. If clinically appropriate, ventilation may be improved by administration of additional anesthetic (eg, propofol or inhalation agent) without further manipulation of the SGA.

Down-folded epiglottis – The tip of the epiglottis can be flipped over as the SGA is placed, resulting in noisy ventilation or airway obstruction. The "up-down maneuver" helps correct this by unfolding the epiglottis [19]. With this maneuver, the SGA is withdrawn 2 to 4 cm and reinserted without deflating the cuff. Head extension, slight advancement or withdrawal, or SGA removal and replacement may also improve ineffective ventilation.

Inadequate seal – Inappropriate sizing may make a seal difficult or impossible. In general, larger sizes create a better seal with lower cuff inflation volumes and pressures compared with smaller sizes [13-15]. The answer to an inadequate seal may be to insert a larger SGA, rather than to add more air to the cuff. In one retrospective review of approximately 19,700 anesthetics involving use of an SGA, use of SGA sizes 2 and 3 was associated with increased incidence of SGA failure [20]. (See 'Choice of size' above.)

Patient anatomy – Placement may be difficult because of anatomical features. If difficulty is experienced with placement, a rotational technique with a partially inflated LMA [21] or even placement with the aid of fiberoptic laryngoscopy or ultrasonography [22] may be helpful.

Choice of mode of ventilation — SGAs can be used with the patient breathing spontaneously or with positive pressure ventilation (PPV). Since the SGA does not seal the pharynx, the pressure that can be safely used to ventilate is limited by leak around the device, with resultant gastric insufflation and/or hypoventilation. Therefore, pressure-limited ventilation (ie, pressure support or pressure control) is usually used with an SGA in place, rather than volume-control ventilation. (See "Mechanical ventilation during anesthesia in adults", section on 'Choice of mode of ventilation'.)

Use of SGAs with spontaneous breathing offers a number of advantages:

Opioids can be titrated according to the patient's respiratory rate.

Gastroesophageal insufflation of air is rarely a problem.

Air leaks around the SGA are less likely than when using PPV.

Some malpositions of the SGA are better tolerated.

On the other hand, PPV with SGA devices offers the following advantages:

PPV allows control of respiratory rate, tidal volume, and minute ventilation.

Hypoventilation is avoided during deep levels of anesthesia and when high doses of opiates are administered.

A number of investigators have explored the use of PPV with SGA devices. Most members of the LMA family, as well as most other SGAs, were designed for use with peak pressures under 20 cmH2O, and numerous studies have shown that leak and gastric insufflation are minimal if peak pressures are kept between 15 and 20 cmH2O [23-27]. The LMA ProSeal was designed for use with higher ventilation pressures (the cuff includes a posterior extension to provide a "double seal") and ordinarily will allow peak airway pressures up to 25 cmH2O before a leak occurs [27-29].

Pressure-controlled ventilation — Pressure-controlled ventilation (PCV) is a mode of PPV commonly used with SGAs. With PCV, the respiratory rate and peak inspiratory pressure are set, along with other parameters. In contrast to volume-controlled ventilation, PCV prevents high peak pressures that can lead to airway gas leaks and gastric insufflation. With an SGA in place, peak pressure is set between 15 and 20 cmH2O, with the rate adjusted to achieve adequate minute ventilation. (See "Mechanical ventilation during anesthesia in adults", section on 'Pressure-controlled ventilation'.)

Pressure support ventilation — We routinely use pressure support ventilation (PSV) with SGAs, though not all anesthesia ventilators allow PSV mode. In PSV mode, the patient initiates each breath, and the ventilator delivers additional support with a preset pressure value. A minimum number of breaths is also set. In this mode, the patient controls his or her own respiratory rate and tidal volume, but if the resultant minute ventilation is too low, the minimum rate or the degree of pressure support can be increased. (See "Mechanical ventilation during anesthesia in adults", section on 'Pressure support'.)

In a randomized crossover study comparing PSV with continuous positive airway pressure (CPAP) using an LMA, PSV at 5 cmH2O above positive end-expiratory pressure (PEEP) resulted in more effective gas exchange compared with spontaneous ventilation with CPAP at 5 cmH2O [30]. In a related trial of 280 patients who underwent general anesthesia with an LMA and were randomly assigned to PEEP at approximately 8 cm H2O versus no PEEP, PEEP slightly improved oxygenation (mean peripheral oxygen saturation [SPO2] 98.5 ± 1.9 versus 98.0 ± 1.4 percent) [31]. PEEP increased the likelihood of needing to reseat the LMA, but did not increase the incidence of gas leak around the LMA.

Use of neuromuscular blocking agents — Neuromuscular blocking agents (NMBAs) can be administered to facilitate SGA placement in order to help prevent gagging, coughing, and laryngospasm, particularly in special circumstances (eg, when thiopental is used for the induction of anesthesia) [32]. In addition, NMBAs can be administered to facilitate endotracheal intubation through an SGA. A study that evaluated the administration of an NMBA during intubation through an intubating LMA reported less coughing and movement during intubation and less difficulty removing the LMA with use of NMBA [33].

NMBAs can be administered to facilitate PPV via an SGA or to reduce the chance of laryngospasm in airway-irritating procedures such as flexible bronchoscopy. Also, NMBAs may be desirable in situations where the surgeon requests muscle relaxation to improve surgical exposure.

SUPRAGLOTTIC AIRWAYS AND THE DIFFICULT AIRWAY — The SGA can serve as an airway rescue device by establishing ventilation and/or by allowing intubation through the device. Case reports have demonstrated that SGAs can be lifesaving in re-establishing an airway when ventilation by facemask and endotracheal intubation is impossible, situations in which a surgical airway would otherwise be required [34]. (See "Management of the difficult airway for general anesthesia in adults".)

If an SGA is used as a rescue device for ventilation after induction of anesthesia, depending on the clinical situation, the decision must be made to either continue the procedure using the SGA, to attempt endotracheal intubation using the SGA as a conduit, or to awaken the patient.

SGAs appear in multiple society guidelines for management of the difficult airway, as options for rescue ventilation after failed intubation or as conduits for endotracheal intubation (algorithm 1 and figure 4) [35-38].

SUPRAGLOTTIC AIRWAYS AS CONDUITS FOR INTUBATION — Once an SGA has been placed, it can act as a conduit for tracheal intubation using one of a number of techniques. Some SGAs (eg, i-gel, LMA Fastrach, air-Q, LMA Protector) permit direct passage of an endotracheal tube (ETT). Standard laryngeal mask airways (LMAs) are too narrow to permit passage of standard-size ETTs.

When an SGA is used for tracheal intubation, the ETT must slide through the SGA without difficulty and the SGA must be easily removed. Dimensional compatibility was investigated in an in vitro study of over 1000 combinations of various SGAs and ETTs, lubricated with medical silicone spray [39]. Failure to slide the ETT through the SGA occurred most commonly with first generation SGAs, almost always because the connector was too narrow. Removal of the SGA was impossible for most wire reinforced ETTs, and successful for all standard ETTs.

Intubating SGAs include features designed to facilitate or improve the success rate of endotracheal intubation. For example, the LMA Fastrach includes a bar that elevates the epiglottis as the ETT passes through the aperture. In addition, a ramp in the Fastrach's intubating tube channel directs the tube centrally and anteriorly in order to minimize the risk of esophageal placement or damage to glottic structures (picture 6).

We prefer to intubate with a flexible intubation scope (FIS) through the SGA, though intubation is possible using a blind technique. The reported first attempt success rate is higher using an FIS than with a blind technique (95 to 100 percent [40] versus 40 to 75 percent [41]).

Use of flexible intubation scope — Two methods have been described for intubation through the SGA using an FIS (see "Flexible scope intubation for anesthesia"):

The ETT can be loaded onto the FIS, and the entire assembly can be passed through the LMA using visual guidance; this requires that the ETT pass easily through the SGA. This method was evaluated in a study in which 44 patients with severe obesity (mean body mass index approximately 39 kg/m2) were randomly assigned to intubation through an i-gel or an Aura Gain SGA [42]. There were no differences in time to intubation, intubation success rate, ease of insertion, or oropharyngeal leak pressure. Intubation time was approximately 55 seconds for both devices.

For cases where the desired ETT is too large in diameter to pass through the SGA, a more complex approach is needed, including the use of an Aintree intubation catheter (AIC), which is a modified airway exchange catheter. The AIC is a 56-cm long, flexible, hollow plastic tube with an internal diameter large enough to accept a pediatric FIS. When used to facilitate intubation through an SGA, a 4-mm FIS is placed through an AIC with several centimeters of scope protruding from the end. The composite assembly is then passed through the SGA well into the trachea under visual guidance. The scope is then removed, followed by the SGA, leaving only the AIC. The desired ETT is then passed over the AIC into position in the trachea. Case reports have described the use of this technique for endotracheal intubation in a patient with a difficult airway because of severe obesity, and as a rescue technique after loss of the airway [43-45].

Note that using the AIC technique allows continuation of ventilation and oxygenation during the intubation process. The catheter has a 22-mm connector to allow positive pressure ventilation (PPV) and oxygen administration.

Blind technique — Studies of blind ETT placement through an SGA with or without the use of an intubating stylet, or bougie, have reported variable success rates. Examples of studies of the success rates of blind techniques for endotracheal intubation through an SGA include the following:

In a prospective trial evaluating blind intubation through the i-gel and the LMA Fastrach devices, overall successful intubation rates were relatively high (82 and 96 percent), with first-attempt success rates of 66 and 74 percent, respectively [46].

In a study comparing the LMA Fastrach and the air-Q, successful blind intubation after two attempts was achieved in 75 out of 76 (99 percent) patients in the LMA Fastrach group versus 60 out of 78 (77 percent) patients in the air-Q group [47]. In another study comparing blind tracheal intubation using the i-gel versus the LMA Fastrach, success was obtained on the first attempt in 69 percent of patients with the i-gel and in 74 percent of patients with the LMA Fastrach [48].

In another study, 120 anesthetized patients were randomly assigned to neck extension or a neutral neck position for blind intubation through the Ambu AuraGain [49]. Overall intubation success rates were 71 percent with neck extension versus 50 percent with neutral neck position. First pass success rates were 68 and 47 percent, respectively.

SPECIAL POPULATIONS AND SCENARIOS — Use of SGAs in infants and children, and in obstetric patients is discussed separately. (See "Airway management for pediatric anesthesia", section on 'Choice of airway device' and "Airway management for the pregnant patient", section on 'Choice of airway devices'.)

Patients with gastroesophageal reflux disease — Since SGAs likely do not offer protection against the aspiration of gastric contents to the same degree as cuffed tracheal tubes, their use for patients at high risk for aspiration under general anesthesia is contraindicated, other than during airway rescue. We routinely choose tracheal intubation rather than SGA placement for patients with significant gastroesophageal reflux disease (GERD). However, SGAs are commonly used in patients with mild GERD that is well controlled with medication, such as proton-pump inhibitors (PPIs).

SGAs with esophageal vents were initially developed to decompress esophageal pressure and allow drainage of gastric contents, and they may be preferred when used for patients with GERD [50-54]. (See 'Aspiration' below.)

Patients with obesity — Patients with obesity are at higher risk for difficult airway management, including difficulty with SGA use. Patients with obesity often require higher peak inspiratory pressures and may therefore be at higher risk for inadequate ventilation with an SGA, leak around the device, and gastric insufflation. (See "Anesthesia for the patient with obesity", section on 'Airway management'.)

There is insufficient literature to assess the safety of SGA use in patients with obesity. A 2013 systematic review that included 232 patients enrolled in two randomized trials compared the use of the LMA ProSeal versus placement of an endotracheal tube (ETT) for patients with obesity (body mass index [BMI] >30 kg/m2) [55]. Leaks were more likely around the laryngeal mask airway (LMA), and the LMA was changed to an ETT in approximately 4 percent of patients because of unsatisfactory placement. No serious complications or cases of aspiration occurred, and postoperative hypoxemia (O2 saturation <92 percent) was less common with LMA use.

Obesity-specific criteria for the use of SGAs have not been established, and practice varies. The author typically avoids use of SGAs for patients with BMI >35 kg/m2, for patients with obesity having surgery that will last longer than 90 minutes, who will be placed in the lithotomy position, and when access to the airway will be limited during the procedure.

Prone position — SGAs have been used for patients having surgery in the prone position, both for planned airway management and as rescue devices [56]. In many cases, patients position themselves prone prior to the induction of anesthesia and placement of the SGA. We place SGAs while the patient is in the prone position in a very select population (eg, patients with no risk factors for difficult airway management) having short procedures that do not require paralysis (eg, rectal surgeries).

Advantages of prone SGA placement include the following [57]:

Induction-to-incision time is shortened, less manpower is needed for positioning, and time to extubation at the conclusion of surgery is usually shorter than when an ETT is placed.

With self-positioning, the patient can confirm that the neck and head positions are comfortable. There may be less chance of injury to the patient or to operating room personnel and less chance of dislodging intravenous (IV) lines or the airway device than with prone positioning after induction.

Hemodynamic changes associated with the prone position may be less with self-positioning.

Disadvantages of the prone SGA include the following:

Higher airway pressures may be required for positive pressure ventilation (PPV) in the prone position, increasing the potential for inadequate ventilation, leak, and/or gastric insufflation.

The SGA provides a less secure airway than an ETT, and manipulation or replacement may be more difficult in the prone position.

A number of studies have evaluated the use of SGAs in the prone position:

A prospective study of 50 patients compared prone positioning before and after induction and LMA placement [57]. There were no complications or cases of airway loss, and induction after positioning resulted in shorter induction-to-incision time and fewer hemodynamic changes after induction.

A retrospective review of 245 cases in which the LMA ProSeal was placed prone reported successful use of the LMA in all patients without complications [58]. In eight patients, the LMA was placed using laryngoscope-guided bougie insertion after one unsuccessful blind insertion, per the institution protocol.

A prospective study compared the i-gel SGA with the LMA Supreme in patients undergoing back surgery [59]. The devices were inserted while the patient was supine. While the i-gel required more attempts at insertion, it provided a higher airway seal pressure. No difference was observed in the fiberoptic views of the vocal cords. The authors concluded that both devices may also be used safely in airway management of patients undergoing lumbar surgery in the prone position.

A prospective audit of 73 patients who positioned themselves prone, followed by induction and LMA placement, reported that one patient developed laryngospasm and that nine required deepening of anesthesia before the LMA could be inserted [60]. LMA malpositioning was encountered in four cases, and in one edentulous patient, it was necessary to hold the LMA for the entire procedure.

For prone SGA placement, we use the following strategy:

We limit prone SGAs to those patients without risk factors for difficult airway management, without limitations in neck movement, and who will undergo short procedures that do not require paralysis (eg, hemorrhoidectomy, rectal fistulotomy). (See "Airway management for induction of general anesthesia", section on 'Airway assessment'.)

We help the patient self-position with the head turned to the side and with the cheek on the edge of the pillow or head support, allowing free access to the face and mouth.

The stretcher is kept in the operating room throughout and after induction of anesthesia, until the anesthesiologist specifically agrees that it can be removed, in order to allow a rapid return to the supine position if necessary for airway management.

We preoxygenate as for routine airway management, induce anesthesia, and prove the ability to mask ventilate prior to SGA placement. (See "Airway management for induction of general anesthesia", section on 'Preoxygenation'.)

We place the SGA and confirm the ability to ventilate as usual.

SUPRAGLOTTIC AIRWAY-RELATED COMPLICATIONS — A number of complications of supraglottic airway (SGA) use have been reported.

Aspiration — SGAs do not fully protect against aspiration of regurgitated stomach contents. The incidence of aspiration with the use of an SGA is unknown, but it is likely low in patients without risk factors for regurgitation. A review of approximately 100 observational studies, abstracts, and studies that were presented in letter form included 12,900 anesthetics with a first-generation laryngeal mask airway (LMA) [61]. There were three cases of aspiration, for an incidence of 1 in 5000, which is similar to the estimated risk of aspiration with the use of a facemask or endotracheal tube (ETT) for airway management [62].

A review of the literature on aspiration with SGAs found that most reported cases occurred in patients with risk factors (ie, upper gastrointestinal disease, full stomach, obesity, multiple trauma), surgical factors (ie, lithotomy position, intraabdominal surgery), and/or anesthesia factors (ie, inadequate depth of anesthesia, SGA cuff deflation) [63].

Esophageal reflux with SGAs — SGA placement may predispose to regurgitation by relaxing the lower esophageal sphincter via a reflex mechanism similar to that which occurs with swallowing a bolus of food. A study including 40 patients under general anesthesia reported that laryngeal mask placement was associated with a 15 percent decrease in lower esophageal sphincter barrier pressure [64]. Studies using pH electrodes have reported that LMAs result in an increase in reflux of stomach acid to the mid to upper esophagus compared with facemask airway management [65,66].

Positioning may influence the degree of reflux with SGA use. Studies using pH electrodes [67] and dye swallowed preoperatively [68] have reported an increase in the incidence of reflux with SGAs when patients are placed in the lithotomy and Trendelenburg positions.

Prevention of aspiration — While reflux into the esophagus can occur with SGAs, the device may act as a plug to prevent aspiration of esophageal contents into the lungs. Vomiting or increase in abdominal pressure can overcome the capacity of the SGA to prevent pharyngeal reflux. Both cadaver and live-patient methodologies have been used to study this issue.

Cadaver studies – Fresh cadaver preparations have been used to study the ability of SGAs to withstand an increase in esophageal pressure [69-72]. Resting intragastric pressure and esophageal pressure during reflux in a fasted patient are usually between 10 and 30 cmH2O [73] and can reach more than 60 cmH2O during vomiting [74]. Cadaver studies have reported that the LMA Classic can prevent regurgitation of esophageal fluid into the pharynx up to 40 to 48 cmH2O [69,70,72] and that the LMA ProSeal with the esophageal vent clamped can seal the esophagus up to 70 cmH2O [69]. With the esophageal vent open, the LMA ProSeal can prevent any increase in esophageal pressure and can drain fluid away from the pharynx [71].

With a similar cadaver preparation, the i-gel SGA with its esophageal lumen clamped was less effective than the LMA Classic or the LMA ProSeal at sealing the esophagus, leaking at 13 cmH2O [54].

Anesthetized patients – In a prospective study of 102 patients under general anesthesia with an LMA ProSeal, dyed saline was introduced down the esophageal vent of the LMA [75]. Fiberoptic laryngoscopy showed no transfer of the dye into the bowl of the LMA in 100 patients; in two patients, dye appeared in the bowl after increased intra-abdominal pressure, one with cough, and one with laryngospasm.

Our approach to minimizing the chance of aspiration with SGAs is as follows:

Carefully select the patient and surgical procedure, considering risk factors for aspiration, expected duration of surgery, surgical site, and positioning. (See "Airway management for induction of general anesthesia", section on 'Supraglottic airway versus endotracheal tube'.)

Maintain an adequate depth of anesthesia for insertion of the SGA and during surgery.

Ensure adequate reversal of neuromuscular blockade prior to emergence from anesthesia.

Minimize peak airway pressure during positive pressure ventilation (PPV) in order to avoid gastric insufflation and distention.

Airway complications — Airway complications with SGA insertion are unusual, with an airway-related critical incident rate of 0.15 percent in one survey study [76]. Potential airway complications include:

Irritation of the oropharyngeal mucosa (especially with excessive cuff pressures).

Injury to teeth, tongue, and lips at the time of insertion.

Injury to the glottic structures (eg, epiglottis, arytenoids).

Injury to the lingual, hypoglossal, recurrent laryngeal, and inferior alveolar nerves (rare) [77-81].

Aspiration of gastric contents. (See 'Aspiration' above.)

Negative pressure pulmonary edema (eg, following vigorous biting of the SGA shaft on emergence from anesthesia, causing airway obstruction) [76].

Pharyngolaryngeal rupture and pneumomediastinum (very rare complications of LMA placement described in case reports) [82].

Laryngospasm (less common at extubation with SGAs than with ETTs, but unlike ETTs, SGAs do not protect against intraoperative laryngospasm) [83].

Role of cuff pressure — The following studies have evaluated the role of increased cuff pressure (beyond 44 mmHg) in the development of SGA-related complications:

In a randomized trial that compared the use of manometry to maintain cuff pressure below 44 mmHg versus standard cuff inflation, the use of manometry resulted in a lower incidence of pharyngolaryngeal adverse events (13.4 versus 45.6 percent) [18]. Significant differences were seen in rates of early dysphonia, early and late dysphagia, and early and late sore throat.

In another randomized trial that compared the use of a built-in cuff pressure monitor versus standard cuff inflation, monitoring resulted in lower combined rates of sore throat, dysphonia, and dysphagia at 1, 2, and 24 hours postoperatively (26 versus 49 percent) [84].

SOCIETY GUIDELINE LINKS — Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See "Society guideline links: Airway management in adults".)

SUMMARY AND RECOMMENDATIONS

Uses of supraglottic airways (SGAs) – SGAs are used for airway management for anesthesia, for primary airway management, as conduits for endotracheal intubation, and for rescue ventilation (algorithm 1). (See 'Routine use of SGAs' above.)

Types of SGAs – SGAs are available in a range of sizes and a variety of styles; some are designed to allow placement of an orogastric tube, while others are designed to allow tracheal intubation through the device. The optimal SGA size for a given patient is one that minimizes leak without excessive cuff inflation (table 1 and table 2). (See 'Choice of SGA' above and 'Choice of size' above.)

SGA placement technique – The usual method for SGA insertion is as follows (figure 3) (see 'Placement technique' above):

Lubricate the cuff with a water-based lubricant.

Hold the device with the index finger of the dominant hand placed at the junction between the cuff and the airway tube.

Press the cuff upward against the hard palate with the index finger, then backward and downward along the palate in a smooth movement until resistance is encountered. As the index finger is removed, hold the SGA down to prevent dislodgment.

Inflate the cuff to a target cuff pressure of around 40 cmH2O or to the minimum pressure needed to create an adequate seal.

Ventilation through SGAs – SGAs can be used with the patient breathing spontaneously or with positive pressure ventilation. Pressure-limited ventilation (ie, pressure support or pressure control) is usually used with an SGA in place, rather than volume-control ventilation. Peak pressures should be kept below 20 cmH2O to minimize leak and gastric insufflation. (See 'Choice of mode of ventilation' above.)

Airway rescue – An SGA can be used as an airway rescue device when mask ventilation is difficult or impossible. It can also be used as a conduit for endotracheal intubation (algorithm 1). (See 'Supraglottic airways and the difficult airway' above and 'Supraglottic airways as conduits for intubation' above.)

Patients with obesity – Use of SGAs in patients with obesity is limited by the potential need for higher peak inspiratory pressures and the possibility of difficult seating of the device. (See 'Patients with obesity' above and "Anesthesia for the patient with obesity", section on 'Choice of airway device'.)

Patients in the prone position – SGAs can be used for airway management in the prone position, as the primary airway device in selected patients, and as rescue devices. We limit prone SGAs to those patients without risk factors for difficult airway management, without limitations in neck movement, and who will undergo short procedures that do not require paralysis (eg, hemorrhoidectomy, rectal fistulotomy). (See 'Prone position' above.)

Complications

SGAs do not provide complete protection against aspiration of stomach contents. (See 'Patients with gastroesophageal reflux disease' above and 'Aspiration' above.)

Other complications of SGA use include failed placement and airway complications, including airway trauma. Sore throat, dysphonia, and dysphagia may be related to high SGA cuff pressures. The cuff inflation should be limited to approximately 44 cmH2O or the minimum volume required for an adequate seal. (See 'Supraglottic airway-related complications' above.)

  1. Castillo-Monzón CG, Gaszyński T, Marroquín-Valz HA, et al. Supraglottic Airway Devices with Vision Guided Systems: Third Generation of Supraglottic Airway Devices. J Clin Med 2023; 12.
  2. Van Zundert AAJ, Gatt SP, Van Zundert TCRV, et al. Features of new vision-incorporated third-generation video laryngeal mask airways. J Clin Monit Comput 2022; 36:921.
  3. Van Zundert AAJ, Kumar CM, Van Zundert TCRV, et al. The case for a 3rd generation supraglottic airway device facilitating direct vision placement. J Clin Monit Comput 2021; 35:217.
  4. Benumof JL. Function of the aperture bars on the LMA. Can J Anaesth 2003; 50:968; author reply 968.
  5. Al-Shaikh B, Pilcher D. Is there a need for the epiglottic bars in the laryngeal mask airway? Can J Anaesth 2003; 50:203.
  6. Terblanche NCS, Middleton C, Choi-Lundberg DL, Skinner M. Efficacy of a new dual channel laryngeal mask airway, the LMA®Gastro™ Airway, for upper gastrointestinal endoscopy: a prospective observational study. Br J Anaesth 2018; 120:353.
  7. Hagan KB, Carlson R, Arnold B, et al. Safety of the LMA®Gastro™ for Endoscopic Retrograde Cholangiopancreatography. Anesth Analg 2020; 131:1566.
  8. Füllekrug B, Pothmann W, Werner C, Schulte am Esch J. The laryngeal mask airway: anesthetic gas leakage and fiberoptic control of positioning. J Clin Anesth 1993; 5:357.
  9. Latorre F, Eberle B, Weiler N, et al. Laryngeal mask airway position and the risk of gastric insufflation. Anesth Analg 1998; 86:867.
  10. Russo SG, Cremer S, Eich C, et al. Magnetic resonance imaging study of the in vivo position of the extraglottic airway devices i-gel™ and LMA-Supreme™ in anaesthetized human volunteers. Br J Anaesth 2012; 109:996.
  11. Yan CL, Chen Y, Sun P, et al. Preliminary evaluation of SaCoVLM™ video laryngeal mask airway in airway management for general anesthesia. BMC Anesthesiol 2022; 22:3.
  12. van Zundert AAJ, Wyssusek KH, Pelecanos A, et al. A prospective randomized comparison of airway seal using the novel vision-guided insertion of LMA-Supreme® and LMA-Protector®. J Clin Monit Comput 2020; 34:285.
  13. Brimacombe J, Keller C. Laryngeal mask airway size selection in males and females: ease of insertion, oropharyngeal leak pressure, pharyngeal mucosal pressures and anatomical position. Br J Anaesth 1999; 82:703.
  14. Berry AM, Brimacombe JR, McManus KF, Goldblatt M. An evaluation of the factors influencing selection of the optimal size of laryngeal mask airway in normal adults. Anaesthesia 1998; 53:565.
  15. Asai T, Howell TK, Koga K, Morris S. Appropriate size and inflation of the laryngeal mask airway. Br J Anaesth 1998; 80:470.
  16. Rao AS, Yew AE, Inbasegaran K. Optimal size selection of laryngeal mask airway in Malaysian female adult population. Med J Malaysia 2003; 58:717.
  17. Wender R, Goldman AJ. Awake insertion of the fibreoptic intubating LMA CTrach in three morbidly obese patients with potentially difficult airways. Anaesthesia 2007; 62:948.
  18. Seet E, Yousaf F, Gupta S, et al. Use of manometry for laryngeal mask airway reduces postoperative pharyngolaryngeal adverse events: a prospective, randomized trial. Anesthesiology 2010; 112:652.
  19. Liu EH, Goy RW, Lim Y, Chen FG. Success of tracheal intubation with intubating laryngeal mask airways: a randomized trial of the LMA Fastrach and LMA CTrach. Anesthesiology 2008; 108:621.
  20. Vannucci A, Rossi IT, Prifti K, et al. Modifiable and Nonmodifiable Factors Associated With Perioperative Failure of Extraglottic Airway Devices. Anesth Analg 2018; 126:1959.
  21. Nakayama S, Osaka Y, Yamashita M. The rotational technique with a partially inflated laryngeal mask airway improves the ease of insertion in children. Paediatr Anaesth 2002; 12:416.
  22. Gupta D, Srirajakalidindi A, Habli N, Haber H. Ultrasound confirmation of laryngeal mask airway placement correlates with fiberoptic laryngoscope findings. Middle East J Anaesthesiol 2011; 21:283.
  23. Devitt JH, Wenstone R, Noel AG, O'Donnell MP. The laryngeal mask airway and positive-pressure ventilation. Anesthesiology 1994; 80:550.
  24. Keller C, Sparr HJ, Luger TJ, Brimacombe J. Patient outcomes with positive pressure versus spontaneous ventilation in non-paralysed adults with the laryngeal mask. Can J Anaesth 1998; 45:564.
  25. von Goedecke A, Brimacombe J, Hörmann C, et al. Pressure support ventilation versus continuous positive airway pressure ventilation with the ProSeal laryngeal mask airway: a randomized crossover study of anesthetized pediatric patients. Anesth Analg 2005; 100:357.
  26. Weiler N, Latorre F, Eberle B, et al. Respiratory mechanics, gastric insufflation pressure, and air leakage of the laryngeal mask airway. Anesth Analg 1997; 84:1025.
  27. Joly N, Poulin LP, Tanoubi I, et al. Randomized prospective trial comparing two supraglottic airway devices: i-gel™ and LMA-Supreme™ in paralyzed patients. Can J Anaesth 2014; 61:794.
  28. Seet E, Rajeev S, Firoz T, et al. Safety and efficacy of laryngeal mask airway Supreme versus laryngeal mask airway ProSeal: a randomized controlled trial. Eur J Anaesthesiol 2010; 27:602.
  29. Jadhav PA, Dalvi NP, Tendolkar BA. I-gel versus laryngeal mask airway-Proseal: Comparison of two supraglottic airway devices in short surgical procedures. J Anaesthesiol Clin Pharmacol 2015; 31:221.
  30. Brimacombe J, Keller C, Hörmann C. Pressure support ventilation versus continuous positive airway pressure with the laryngeal mask airway: a randomized crossover study of anesthetized adult patients. Anesthesiology 2000; 92:1621.
  31. Ullmann H, Renziehausen L, Geil D, et al. The Influence of Positive End-Expiratory Pressure on Leakage and Oxygenation Using a Laryngeal Mask Airway: A Randomized Trial. Anesth Analg 2022; 135:769.
  32. Yoshino A, Hashimoto Y, Hirashima J, et al. Low-dose succinylcholine facilitates laryngeal mask airway insertion during thiopental anaesthesia. Br J Anaesth 1999; 83:279.
  33. van Vlymen JM, Coloma M, Tongier WK, White PF. Use of the intubating laryngeal mask airway: are muscle relaxants necessary? Anesthesiology 2000; 93:340.
  34. Cook TM, Brooks TS, Van der Westhuizen J, Clarke M. The Proseal LMA is a useful rescue device during failed rapid sequence intubation: two additional cases. Can J Anaesth 2005; 52:630.
  35. Apfelbaum JL, Hagberg CA, Connis RT, et al. 2022 American Society of Anesthesiologists Practice Guidelines for Management of the Difficult Airway. Anesthesiology 2022; 136:31.
  36. Law JA, Duggan LV, Asselin M, et al. Canadian Airway Focus Group updated consensus-based recommendations for management of the difficult airway: part 2. Planning and implementing safe management of the patient with an anticipated difficult airway. Can J Anaesth 2021; 68:1405.
  37. Law JA, Duggan LV, Asselin M, et al. Canadian Airway Focus Group updated consensus-based recommendations for management of the difficult airway: part 1. Difficult airway management encountered in an unconscious patient. Can J Anaesth 2021; 68:1373.
  38. Frerk C, Mitchell VS, McNarry AF, et al. Difficult Airway Society 2015 guidelines for management of unanticipated difficult intubation in adults. Br J Anaesth 2015; 115:827.
  39. Moser B, Kemper M, Kleine-Brueggeney M, et al. Dimensional compatibility and limitations of tracheal intubation through supraglottic airway devices: a mannequin-based in vitro study. Can J Anaesth 2021; 68:1337.
  40. Michálek P, Donaldson W, McAleavey F, et al. The i-gel Supraglottic Airway as a Conduit for Fibreoptic Tracheal Intubation - A Randomized Comparison with the Single-use Intubating Laryngeal Mask Airway and CTrach Laryngeal Mask in Patients with Predicted Difficult Laryngoscopy. Prague Med Rep 2016; 117:164.
  41. Ahn E, Choi G, Kang H, et al. Supraglottic airway devices as a strategy for unassisted tracheal intubation: A network meta-analysis. PLoS One 2018; 13:e0206804.
  42. Moser B, Keller C, Audigé L, et al. Fiberoptic intubation of severely obese patients through supraglottic airway: A prospective, randomized trial of the Ambu® AuraGain™ laryngeal mask vs the i-gel™ airway. Acta Anaesthesiol Scand 2019; 63:187.
  43. Doyle DJ, Zura A, Ramachandran M, et al. Airway management in a 980-lb patient: use of the Aintree intubation catheter. J Clin Anesth 2007; 19:367.
  44. Avitsian R, Doyle DJ, Helfand R, et al. Successful reintubation after cervical spine exposure using an Aintree intubation catheter and a Laryngeal Mask Airway. J Clin Anesth 2006; 18:224.
  45. Farag E, Bhandary S, Deungria M, et al. Successful emergent reintubation using the Aintree intubation catheter and a laryngeal mask airway. Minerva Anestesiol 2010; 76:148.
  46. Kapoor S, Jethava DD, Gupta P, et al. Comparison of supraglottic devices i-gel(®) and LMA Fastrach(®) as conduit for endotracheal intubation. Indian J Anaesth 2014; 58:397.
  47. Karim YM, Swanson DE. Comparison of blind tracheal intubation through the intubating laryngeal mask airway (LMA Fastrach™) and the Air-Q™. Anaesthesia 2011; 66:185.
  48. Halwagi AE, Massicotte N, Lallo A, et al. Tracheal intubation through the I-gel™ supraglottic airway versus the LMA Fastrach™: a randomized controlled trial. Anesth Analg 2012; 114:152.
  49. Yoo S, Park SK, Kim WH, et al. The effect of neck extension on success rate of blind intubation through Ambu® AuraGain™ laryngeal mask: a randomized clinical trial. Can J Anaesth 2019; 66:639.
  50. Evans NR, Llewellyn RL, Gardner SV, James MF. Aspiration prevented by the ProSeal laryngeal mask airway: a case report. Can J Anaesth 2002; 49:413.
  51. Keller C, Brimacombe J, von Goedecke A, Lirk P. Airway protection with the ProSeal laryngeal mask airway in a child. Paediatr Anaesth 2004; 14:1021.
  52. Goldmann K, Jakob C. Prevention of aspiration under general anesthesia by use of the size 2 1/2 ProSeal laryngeal mask airway in a 6-year-old boy: a case report. Paediatr Anaesth 2005; 15:886.
  53. Gibbison B, Cook TM, Seller C. Case series: Protection from aspiration and failure of protection from aspiration with the i-gel airway. Br J Anaesth 2008; 100:415.
  54. Schmidbauer W, Bercker S, Volk T, et al. Oesophageal seal of the novel supralaryngeal airway device I-Gel in comparison with the laryngeal mask airways Classic and ProSeal using a cadaver model. Br J Anaesth 2009; 102:135.
  55. Nicholson A, Cook TM, Smith AF, et al. Supraglottic airway devices versus tracheal intubation for airway management during general anaesthesia in obese patients. Cochrane Database Syst Rev 2013; :CD010105.
  56. Dingeman RS, Goumnerova LC, Goobie SM. The use of a laryngeal mask airway for emergent airway management in a prone child. Anesth Analg 2005; 100:670.
  57. Weksler N, Klein M, Rozentsveig V, et al. Laryngeal mask in prone position: pure exhibitionism or a valid technique. Minerva Anestesiol 2007; 73:33.
  58. Brimacombe JR, Wenzel V, Keller C. The proseal laryngeal mask airway in prone patients: a retrospective audit of 245 patients. Anaesth Intensive Care 2007; 35:222.
  59. Kang F, Li J, Chai X, et al. Comparison of the I-gel laryngeal mask airway with the LMA-supreme for airway management in patients undergoing elective lumbar vertebral surgery. J Neurosurg Anesthesiol 2015; 27:37.
  60. Ng A, Raitt DG, Smith G. Induction of anesthesia and insertion of a laryngeal mask airway in the prone position for minor surgery. Anesth Analg 2002; 94:1194.
  61. Brimacombe JR, Berry A. The incidence of aspiration associated with the laryngeal mask airway: a meta-analysis of published literature. J Clin Anesth 1995; 7:297.
  62. Warner MA, Warner ME, Weber JG. Clinical significance of pulmonary aspiration during the perioperative period. Anesthesiology 1993; 78:56.
  63. Keller C, Brimacombe J, Bittersohl J, et al. Aspiration and the laryngeal mask airway: three cases and a review of the literature. Br J Anaesth 2004; 93:579.
  64. Rabey PG, Murphy PJ, Langton JA, et al. Effect of the laryngeal mask airway on lower oesophageal sphincter pressure in patients during general anaesthesia. Br J Anaesth 1992; 69:346.
  65. Owens TM, Robertson P, Twomey C, et al. The incidence of gastroesophageal reflux with the laryngeal mask: a comparison with the face mask using esophageal lumen pH electrodes. Anesth Analg 1995; 80:980.
  66. Roux M, Drolet P, Girard M, et al. Effect of the laryngeal mask airway on oesophageal pH: influence of the volume and pressure inside the cuff. Br J Anaesth 1999; 82:566.
  67. McCrory CR, McShane AJ. Gastroesophageal reflux during spontaneous respiration with the laryngeal mask airway. Can J Anaesth 1999; 46:268.
  68. el Mikatti N, Luthra AD, Healy TE, Mortimer AJ. Gastric regurgitation during general anaesthesia in different positions with the laryngeal mask airway. Anaesthesia 1995; 50:1053.
  69. Bercker S, Schmidbauer W, Volk T, et al. A comparison of seal in seven supraglottic airway devices using a cadaver model of elevated esophageal pressure. Anesth Analg 2008; 106:445.
  70. Keller C, Brimacombe J, Rädler C, Pühringer F. Do laryngeal mask airway devices attenuate liquid flow between the esophagus and pharynx? A randomized, controlled cadaver study. Anesth Analg 1999; 88:904.
  71. Keller C, Brimacombe J, Kleinsasser A, Loeckinger A. Does the ProSeal laryngeal mask airway prevent aspiration of regurgitated fluid? Anesth Analg 2000; 91:1017.
  72. Brimacombe J, Keller C. Water flow between the upper esophagus and pharynx for the LMA and COPA in fresh cadavers. Laryngeal mask airway, and cuffed oropharyngeal airway. Can J Anaesth 1999; 46:1064.
  73. Holloway RH, Hongo M, Berger K, McCallum RW. Gastric distention: a mechanism for postprandial gastroesophageal reflux. Gastroenterology 1985; 89:779.
  74. MARCHAND P. A study of the forces productive of gastro-oesophageal regurgitation and herniation through the diaphragmatic hiatus. Thorax 1957; 12:189.
  75. Evans NR, Gardner SV, James MF. ProSeal laryngeal mask protects against aspiration of fluid in the pharynx. Br J Anaesth 2002; 88:584.
  76. Verghese C, Brimacombe JR. Survey of laryngeal mask airway usage in 11,910 patients: safety and efficacy for conventional and nonconventional usage. Anesth Analg 1996; 82:129.
  77. Zhang J, Zhao Z, Chen Y, Zhang X. New insights into the mechanism of injury to the recurrent laryngeal nerve associated with the laryngeal mask airway. Med Sci Monit 2010; 16:HY7.
  78. Brimacombe J, Clarke G, Keller C. Lingual nerve injury associated with the ProSeal laryngeal mask airway: a case report and review of the literature. Br J Anaesth 2005; 95:420.
  79. Nagai K, Sakuramoto C, Goto F. Unilateral hypoglossal nerve paralysis following the use of the laryngeal mask airway. Anaesthesia 1994; 49:603.
  80. Stewart A, Lindsay WA. Bilateral hypoglossal nerve injury following the use of the laryngeal mask airway. Anaesthesia 2002; 57:264.
  81. Hanumanthaiah D, Ranganath A. Inferior alveolar nerve injury with laryngeal mask airway: a case report. J Med Case Rep 2011; 5:560.
  82. Atalay YO, Kaya C, Aktas S, Toker K. A complication of the laryngeal mask airway: Pharyngolaryngeal rupture and pneumomediastinum. Eur J Anaesthesiol 2015; 32:439.
  83. Yu SH, Beirne OR. Laryngeal mask airways have a lower risk of airway complications compared with endotracheal intubation: a systematic review. J Oral Maxillofac Surg 2010; 68:2359.
  84. Wong DT, Tam AD, Mehta V, et al. New supraglottic airway with built-in pressure indicator decreases postoperative pharyngolaryngeal symptoms: a randomized controlled trial. Can J Anaesth 2013; 60:1197.
Topic 98733 Version 37.0

References

آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟